The University of Chicago Header Logo

Connection

Nitasha Sarswat to RNAi Therapeutics

Back to Details
This is a "connection" page, showing publications Nitasha Sarswat has written about RNAi Therapeutics.
Nitasha Sarswat
Connection Strength
0.247
RNAi Therapeutics
  1. Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B. J Am Coll Cardiol. 2026 Sep 22; 88(12):1402-1412.
    View in: PubMed
    Score: 0.247
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.